Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/04/051466
CTRI/2023/04/051466
Not yet recruiting
未知

A Prospective Study on Safety and Effectiveness in Softening, Lightening, and Flattening Raised Scars while Maintaining Skin Moisture and Relieving Discomfort.

ENNOGEN Healthcare International Limited0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ENNOGEN Healthcare International Limited
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
ENNOGEN Healthcare International Limited

Eligibility Criteria

Inclusion Criteria

  • •1\. Paediatric (Children \> 3 months) and adults
  • •2\. Subjects who are healthy or medically fit
  • •3\. Subjects who are willing to participate and able to follow study requirements
  • •4\. Subjects having recent scars and immature scars (6 months to 1 year)
  • •5\. Subjects having scars on the body parts, face, joints, flexures, hairy areas, and large area scars such as those caused by burns (less than 5%) or trauma and surgical/suture scars
  • •6\. Etiology and clinical assessment of the scar indicate that it could benefit from the study treatments
  • •7\. Only to be used on intact skin form of healing

Exclusion Criteria

  • •1\. Subjects with chronic skin diseases such as psoriasis, chronic dermatitis, and allergies
  • •2\. Subjects have a history of silicone allergy/sensitivity to rosehip oil, Ximenia oil, sandalwood oil, vitamin E acetate, or ascorbyl tetraisopalmitate
  • •3\. Subjects who are medically unfit
  • •4\. Pregnant subjects or those attempting to become pregnant
  • •5\. Subjects with known immunosuppression or immunosuppressive illness
  • •6\. Subjects with known sensitivity to ingredients in the test treatment products
  • •7\. Subjects having open wounds or sutures not removed
  • •8\. Subjects having no visible scars

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A Prospective study of the Safety and Effectiveness of Uterine Artery Embolization for the treatment of Endometriosis (UAE-E) – a Pilot StudyEndometriosisReproductive Health and Childbirth - Other reproductive health and childbirth disorders
ACTRN12622001301752The Alfred Hospital6
Completed
Phase 3
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor SubjectsMedication Refractory Essential Tremor
JPRN-UMIN000033752Medical Corporation Tokushukai Shonanfujisawa Tokushukai Hospital10
Completed
Not Applicable
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor SubjectsEssential Tremor
JPRN-UMIN000023639Departments of Neurology and Neurosurgery, Hokuto Hospital10
Completed
Phase 3
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor SubjectsMedication Refractory Essential Tremor
JPRN-UMIN000019498Department of Neurosurgery, Osaka University School of Medicine10
Recruiting
Not Applicable
An Observational Study on Effectiveness and Safety of Akalux and BioBlade Laser System Based Illuminox Treatment in Patients with Locally Advanced or Recurrent Head and Neck Cancer
JPRN-jRCT1041210120Hanai Nobuhiro75